E2F1 and gastrointestinal stromal tumor: Using a cohort comparable to ours, including only primary, treatment‐naïve, high‐risk GIST, samples with higher mitotic counts were shown to have a significantly increased protein expression of cyclin D1, p53 and E2F1 [17].